VIR
NASDAQ · Biotechnology
Vir Biotechnology Inc
$9.16
-0.14 (-1.51%)
Open$9.43
Previous Close$9.30
Day High$9.81
Day Low$9.01
52W High$11.66
52W Low$4.16
Volume—
Avg Volume2.31M
Market Cap1.54B
P/E Ratio—
EPS$-3.16
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+85.4% upside
Current
$9.16
$9.16
Target
$16.98
$16.98
$13.41
$16.98 avg
$22.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 88.80M | 254.58M | 113.39M |
| Net Income | -567,324,917 | -1,463,854,430 | -30,823,495 |
| Profit Margin | -638.9% | -606.9% | -27.2% |
| EBITDA | -620,363,041 | -1,689,635,576 | -42,153,177 |
| Free Cash Flow | — | — | -22,930,380 |
| Rev Growth | -65.1% | -65.1% | +24.3% |
| Debt/Equity | — | — | 0.94 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |